Cheng, Yezhe
13  results:
Search for persons X
?
3

Randomized, double-blinded, placebo-controlled phase I stud..:

Li, Na ; Du, Shuangqing ; Wang, Ying...
European Journal of Pharmaceutical Sciences.  176 (2022)  - p. 106257 , 2022
 
?
5

Comparative Pharmacokinetics and Bioavailability of Three E..:

Cheng, Yezhe ; Zhang, Yu ; Xing, Hang...
Evidence-Based Complementary and Alternative Medicine.  2017 (2017)  - p. 1-12 , 2017
 
?
6

Renoprotective Effects of Total Glucosides from Paeony agai..:

Lv, Mingming ; Zhang, Meiyu ; Cheng, Yezhe...
Evidence-Based Complementary and Alternative Medicine.  2017 (2017)  - p. 1-9 , 2017
 
?
7

Corrigendum to "Systematic screening and characterization o..:

Zhang, Yu ; Cheng, Yezhe ; Liu, Zhongbo...
Journal of Chromatography B.  1064 (2017)  - p. 160-161 , 2017
 
?
8

Systematic screening and characterization of multiple const..:

Zhang, Yu ; Cheng, Yezhe ; Liu, Zhongbo...
Journal of Chromatography B.  1061-1062 (2017)  - p. 474-486 , 2017
 
?
9

Corrigendum: Preclinical profiles of SKB264, a novel anti-T..:

Cheng, Yezhe ; Yuan, Xiaoxi ; Tian, Qiang...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10762306/.  , 2023
 
?
10

Corrigendum: Preclinical profiles of SKB264, a novel anti-T..:

Yezhe Cheng ; Xiaoxi Yuan ; Qiang Tian...
https://www.frontiersin.org/articles/10.3389/fonc.2023.1334938/full.  , 2023
 
?
11

Preclinical profiles of SKB264, a novel anti-TROP2 antibody..:

Yezhe Cheng ; Xiaoxi Yuan ; Qiang Tian...
https://www.frontiersin.org/articles/10.3389/fonc.2022.951589/full.  , 2022
 
1-13